                         SEQUENCE LISTING

<110>  SERVICIO ANDALUZ DE SALUD
       FUNDACI INSTITUT DE RECERCA BIOMDICA (IRB BARCELONA)
       HOSPITAL CLNIC DE BARCELONA
        INSTITUT D'INVESTIGACIONS BIOMDIQUES AUGUST PI I SUNYER 
       (IDIBAPS)
       UNIVERSIDAD DE SEVILLA
       UNIVERSITAT DE BARCELONA
       FUNDACI PRIVADA INSTITUT DE SALUT GLOBAL BARCELONA
 
<120>  Peptides against anti-outer membrane protein A (OmpA) to treat 
       infections caused by Gram negative pathogens

<130>  P3145PC00

<150>  ES201431400
<151>  2014-09-25

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)

<400>  1

Trp Pro Arg Trp Pro Arg 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)

<400>  2

Arg Pro Trp Arg Pro Trp 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)

<400>  3

Arg Pro Trp Arg Pro Trp 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)

<400>  4

Arg Pro Trp Arg Pro Trp 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)

<400>  5

Trp Pro Arg Trp Pro Arg 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)  wherein the
       two Proline residues are D-Proline aminoacids

<400>  6

Trp Pro Arg Arg Pro Trp 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein the 
       two Proline residues are D-Proline aminoacids

<400>  7

Trp Pro Trp Arg Pro Arg 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein Pro 
       residue is a D-Proline residue


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Pro(NH2)

<400>  8

Trp Xaa Arg Trp Pro Arg 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein the 
       two Proline residues are D-Proline aminoacids

<400>  9

Tyr Pro Ala Tyr Pro Ala 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)  wherein Pro
       residues are D-Proline residues


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  3Pal

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  3Pal

<400>  10

Xaa Pro Arg Xaa Pro Arg 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein Pro 
       residues are D-Proline residues


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  2Nal

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  2Nal

<400>  11

Xaa Pro Arg Xaa Pro Arg 
1               5       


<210>  12
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)  wherein Pro
       residues are D-Proline residues


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  2Nal

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  3Pal

<400>  12

Xaa Pro Arg Xaa Pro Arg 
1               5       


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein Pro 
       residues are D-Proline residues


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  3Pal

<400>  13

Xaa Pro Arg Trp Pro Tyr 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein Pro 
       residues are D-Proline residues


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Dab

<400>  14

Trp Pro Xaa Trp Pro Xaa 
1               5       


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)  wherein the
       two Proline residues are D-Proline aminoacids

<400>  15

Trp Pro Lys Trp Pro Lys 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA) wherein the 
       two Proline residues are D-Proline aminoacids

<400>  16

Arg Pro Cys Arg Pro Cys 
1               5       


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)  wherein the
       two Proline residues are D-Proline aminoacids

<400>  17

Ala Pro Cys Ala Pro Cys 
1               5       


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide against anti-outer membrane protein A (OmpA)  wherein the
       two Proline residues are D-Proline aminoacids

<400>  18

Ser Pro Cys Ser Pro Cys 
1               5       


